A detailed history of Clearbridge Investments, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 533,693 shares of CORT stock, worth $35.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
533,693
Previous 570,816 6.5%
Holding current value
$35.7 Million
Previous $18.5 Million 33.12%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$29.51 - $46.26 $1.1 Million - $1.72 Million
-37,123 Reduced 6.5%
533,693 $24.7 Million
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $256,281 - $397,864
-11,539 Reduced 1.98%
570,816 $18.5 Million
Q1 2024

May 13, 2024

BUY
$21.1 - $27.46 $12.3 Million - $16 Million
582,355 New
582,355 $14.7 Million
Q4 2019

Feb 14, 2020

SELL
$12.06 - $16.96 $4,305 - $6,054
-357 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$10.41 - $14.66 $3,716 - $5,233
357 New
357 $5,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.